Thyroid function and perfluoroalkyl acids in children living near a chemical plant

Environmental Health Perspectives

Volumn 120, Issue 7, 2012, Pages 1036-1041

  Lopez Espinosa, Maria Jose ^a   Mondal, Debapriya ^a   Armstrong, Ben ^a   Bloom, Michael S ^b,c   Fletcher, Tony ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c UNIVERSITY AT ALBANY   (United States)

Author keywords

Children; PFAA; PFNA; PFOA; PFOS; T4; Thyroid disease; Thyroid hormones; TSH

Indexed keywords

LEVOTHYROXINE SODIUM; PERFLUORONONANOIC ACID; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; THIAMAZOLE;

ADOLESCENT; ARTICLE; CHEMICAL INDUSTRY; CHILD; ENZYME IMMUNOASSAY; FEMALE; HASHIMOTO DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; SCHOOL CHILD; THYROID DISEASE; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ADOLESCENT; ALKANESULFONIC ACIDS; CHILD; CHILD, PRESCHOOL; ENVIRONMENTAL POLLUTANTS; FEMALE; FLUOROCARBONS; HUMANS; INFANT; MALE; OCTANOIC ACIDS; QUESTIONNAIRES; THYROID GLAND; THYROID HORMONES; THYROTROPIN; THYROXINE;

ANIMALIA;

EID: 84861666041     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1104370     Document Type: Article

References (34)

1. Anderson GW. 2001. Thyroid hormones and the brain. Front Neuroendocrinol 22:1-17.
2. Bernal J. 2007. Thyroid hormone receptors in brain development and function. Nat Clin Pract Endocrinol Metab 3:249-259.
3. Bloom MS, Kannan K, Spliethoff HM, Tao L, Aldous KM, Vena JE. 2010. Exploratory assessment of perfluorinated compounds and human thyroid function. Physiol Behav 99:240-245.
4. Boas M, Main KM, Feldt-Rasmussen U. 2009. Environmental chemicals and thyroid function: an update. Curr Opin Endocrinol Diabetes Obes 16:385-391.
5. Butenhoff J, Costa G, Elcombe C, Farrar D, Hansen K, Iwai H, et al. 2002. Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months. Toxicol Sci 69:244-257.
6. CDC Epi Info. 2010. Epi Info™ 7. Available: http://www.cdc.gov/epiinfo [accessed 12 March 2011].
7. Chan E, Burstyn I, Cherry N, Bamforth F, Martin JW. 2011. Perfluorinated acids and hypothyroxinemia in pregnant women. Environ Res 111:559-564.
8. Chang SC, Thibodeaux JR, Eastvold ML, Ehresman DJ, BjorkJA, Froehlich JW, et al. 2007. Negative bias from analog methods used in the analysis of free thyroxine in rat serum containing perfluorooctanesulfonate (PFOS). Toxicology 234:21-33.
9. Dallaire R, Dewailly É, Pereg D, Dery S, Ayotte P. 2009. Thyroid function and plasma concentrations of polyhalogenated compounds in Inuit adults. Environ Health Perspect 117:1380-1386.
10. Emmett EA, Zhang H, Shofer FS, Freeman D, Rodway NV, DesaiC, et al. 2006. Community exposure to perfluorooctanoate: relationships between serum levels and certain health parameters. J Occup Environ Med 48:771-779.
11. Freire C, Ramos R, Amaya E, Fernandez MF, Santiago-FernandezP, Lopez-Espinosa MJ, et al. 2010. Newborn TSH concentration and its association with cognitive development in healthy boys. Eur J Endocrinol 163:901-909.
12. Frisbee SJ, Brooks AP, Maher A, Flensborg P, Arnold S, FletcherT, et al. 2009. The C8 health project: design, methods, and participants. Environ Health Perspect 117:1873-1882.
13. Hunter I, Greene SA, MacDonald TM, Morris AD. 2000. Prevalence and aetiology of hypothyroidism in the young. Arch Dis Child 83:207-210.
14. Inoue K, Okada F, Ito R, Kato S, Sasaki S, Nakajima S, et al. 2004. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy. Environ Health Perspect 112:1204-1207.
15. Kato K, Wong LY, Jia LT, Kuklenyik Z, Calafat AM. 2011. Trends in exposure to polyfluoroalkyl chemicals in the U.S. population: 1999-2008. Environ Sci Technol 45:8037-8045.
16. Kim S, Choi K, Ji K, Seo J, Kho Y, Park J, et al. 2011. Trans-placental transfer of thirteen perfluorinated compounds and relations with fetal. thyroid hormones. Environ Sci Technol 45:7465-7472.
17. Knox SS, Jackson T, Frisbee SJ, Javins B, Ducatman AM. 2011. Perfluorocarbon exposure, gender and thyroid function in the C8 Health Project. J Toxicol Sci 36:403-410.
18. Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, SeedJ. 2007. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 99:366-394.
19. Liu Y, Wang J, Fang X, Zhang H, Dai J. 2011. The thyroid-disrupting effects of long-term perfluorononanoate exposure on zebrafish (Danio rerio). Ecotoxicology 20:47-55.
20. Lopez-Espinosa MJ, Fitz-Simon N, Bloom MS, Calafat AM, Fletcher T. 2011a. Comparison between free serum thyroxine levels, measured by analog and dialysis methods, in the presence of perfluorooctane sulfonate and perfluorooctanoate. Reprod Toxicol 33(4):552-555.
21. Lopez-Espinosa MJ, Fletcher T, Armstrong B, Genser B, Dhatariya K, Mondal D, et al. 2011b. Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with age of puberty among children living near a chemical plant. Environ Sci Technol 45:8160-8166.
22. 4, PRL, cortisol and testosterone in healthy volunteers. Clin Endocrinol (Oxf) 46:587-598.
23. Melzer D, Rice N, Depledge MH, Henley WE, Galloway TS. 2010. Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey. Environ Health Perspect 118:686-692.
24. Mondal D, Lopez-Espinosa MJ, Armstrong B, Stein CR, FletcherT. 2012. Relationships of perfluorooctanoate and perfluorooctane sulfonate serum concentrations between mother-child pairs in a population with perfluorooctanoate exposure from drinking water. Environ Health Perspect 120:752-757.
25. Olsen GW, Burris JM, Burlew MM, Mandel JH. 2003. Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. JOccup Environ Med 45:260-270.
26. Olsen GW, Zobel LR. 2007. Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers. Int Arch Occup Environ Health 81:231-246.
27. Papi G, Uberti ED, Betterle C, Carani C, Pearce EN, BravermanLE, et al. 2007. Subclinical hypothyroidism. Curr Opin Endocrinol Diabetes Obes 14:197-208.
28. Porterfield SP, Hendrich CE. 1993. The role of thyroid hormones in prenatal and neonatal neurological development-current perspectives. Endocr Rev 14:94-106.
29. Pop VJ, Kuijpens JL, van Baar AL, Verkerk G, van Son MM, de Vijlder JJ, et al. 1999. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol (Oxf), 50:149-155.
30. Rice D, Barone S. 2000. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 108(suppl 3):511-533.
31. Shin HM, Vieira VM, Ryan PB, Detwiler R, Sanders B, SteenlandK, et al. 2011a. Environmental fate and transport modeling for perfluorooctanoic acid emitted from the Washington Works Facility in West Virginia. 2011. Environ Sci Technol 45:1435-1442.
32. Shin HM, Vieira VM, Ryan PB, Steenland K, Bartell SM. 2011b. Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 Health Project. Environ Health Perspect 119:1760-1765.
33. Steenland K, Fletcher T, Savitz DA. 2010. Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA). Environ Health Perspect 118:1100-1108.
34. Wu T, Flowers JW, Tudiver F, Wilson JL, Punyasavatsut N. 2006. Subclinical thyroid disorders and cognitive performance among adolescents in the United States. BMC Pediatr 6:12.